| |
| |
|
| Insider
Information: |
Scanlon Meghan |
| Relationship: |
|
| City: |
Marlborough |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
50,668 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,032,437 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
50,668 |
|
|
| Total
Value |
$2,032,437 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Boston Scientific Corp |
BSX |
SVP,Pres,Urology Pelvi... |
2022-05-01 |
24,461 |
2020-02-21 |
0 |
Premium* |
|
|
Paragon 28, Inc. |
FNA |
|
2023-05-17 |
26,207 |
2022-04-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
44 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BSX |
Boston Scientific Corp |
SVP,Pres,Urology Pelvic Health |
• • – |
2020-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
778 |
8,099 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP,Pres,Urology Pelvic Health |
• • – |
2020-02-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,159 |
8,994 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP,Pres,Urology Pelvic Health |
• • – |
2020-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,227 |
9,890 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP,Pres,Urology Pelvic Health |
• • – |
2020-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,018 |
10,549 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP,Pres,Urology Pelvic Health |
• • – |
2020-05-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,061 |
12,301 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP,Pres,Urology Pelvic Health |
• • – |
2020-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
854 |
12,529 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP,Pres,Urology Pelvic Health |
• • – |
2021-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,107 |
13,927 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP,Pres,Urology Pelvic Health |
• • – |
2021-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,111 |
14,650 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP,Pres,Urology Pelvic Health |
• • – |
2021-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
779 |
15,057 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP,Pres,Urology Pelvic Health |
• • – |
2021-02-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,159 |
15,993 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP,Pres,Urology Pelvic Health |
• • – |
2021-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,018 |
16,673 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP,Pres,Urology Pelvic Health |
• • – |
2021-05-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,061 |
18,435 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP,Pres,Urology Pelvic Health |
• • – |
2021-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
855 |
18,685 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP,Pres,Urology Pelvic Health |
• • – |
2022-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,108 |
20,250 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP,Pres,Urology Pelvic Health |
• • – |
2022-02-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,583 |
21,445 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP,Pres,Urology Pelvic Health |
• • – |
2022-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,112 |
22,063 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP,Pres,Urology Pelvic Health |
• • – |
2022-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
779 |
22,515 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP,Pres,Urology Pelvic Health |
• • – |
2022-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,019 |
23,305 |
0 |
- |
|
| FNA |
Paragon 28, Inc. |
Director |
– • – |
2022-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
17,846 |
17,846 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP,Pres,Urology Pelvic Health |
• • – |
2022-05-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,062 |
25,067 |
0 |
- |
|
| FNA |
Paragon 28, Inc. |
|
• • – |
2023-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
8,361 |
26,207 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP,Pres,Urology Pelvic Health |
• • – |
2021-06-24 |
4 |
OE |
$17.26 |
$283,927 |
D/D |
16,450 |
34,280 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP,Pres,Urology Pelvic Health |
• • – |
2021-07-27 |
4 |
OE |
$23.41 |
$324,229 |
D/D |
13,850 |
32,992 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP,Pres,Urology Pelvic Health |
• • – |
2020-07-01 |
4 |
D |
$35.28 |
$9,173 |
D/D |
(260) |
12,269 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP,Pres,Urology Pelvic Health |
• • – |
2020-05-01 |
4 |
D |
$35.99 |
$22,530 |
D/D |
(626) |
11,675 |
0 |
- |
|
44 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
